CL
Colgate-Palmolive Company
NYSE · Consumer Defensive · Household & Personal Products · US
$88.77
−1.47%Year over year
Reported trailing growth
- Revenue
- +5.2%
- EBITDA
- -19.8%
- EBIT
- -0.2%
- EPS
- -28.9%
- Free cash flow
- +14.5%
- Operating cash flow
- +13.7%
Forward estimates
Based on analyst estimates
- Revenue
- +3.2%
- EBITDA
- +41.6%
- EPS
- +54.6%
Three-year CAGR
- Revenue
- +4.3%
- EBITDA
- +5.5%
- EBIT
- +6.6%
- Net income
- +6.1%
- EPS
- +7.4%
- Free cash flow
- +25.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026